Bicarbonate

Bicarbonate

SCHEMBL357950

CC[n+]1ccn(C)c1.O=C([O-])O

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.34
HSP90AA1 P07900 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
FDPS P14324 6/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL2936301 0.94 MEN1 (0.35) MEN1HSP90AA1KMT2ASMN1; SMN2FDPS
Acetic Acid SCHEMBL28506135 0.93 MEN1 (0.36) MEN1HSP90AA1KMT2ASMN1; SMN2FDPS
Acetic Acid SCHEMBL302142 0.92 MEN1 (0.37) MEN1HSP90AA1KMT2ASMN1; SMN2FDPS
Bicarbonate SCHEMBL2229450 0.92 MEN1 (0.34) MEN1HSP90AA1KMT2ASMN1; SMN2FDPS
Oxalic Acid SCHEMBL29142278 0.91 MEN1 (0.35) MEN1HSP90AA1KMT2ASMN1; SMN2FDPS
Acetic Acid SCHEMBL28948439 0.91 MEN1 (0.36) MEN1HSP90AA1KMT2ASMN1; SMN2FDPS
Acetic Acid SCHEMBL28087150 0.91 MEN1 (0.40) MEN1HSP90AA1KMT2ASMN1; SMN2FDPS
Propionic Acid SCHEMBL508029 0.91 MEN1 (0.33) MEN1HSP90AA1KMT2ASMN1; SMN2FDPS
Acetic Acid SCHEMBL20338489 0.91 MEN1 (0.36) MEN1HSP90AA1KMT2ASMN1; SMN2FDPS
Acetic Acid SCHEMBL28802048 0.90 MEN1 (0.38) MEN1HSP90AA1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119661373-A TATB crystal with fusiform micro-nano hierarchical structure and preparation method thereof 中国工程物理研究院化工材料研究所 2025-03-21 CN claimed
CN-114456019-B Porous TATB explosive spherulite and preparation method thereof 中国工程物理研究院化工材料研究所 2022-11-15 CN claimed
CN-107710462-B Electrochemical hydrogen storage electrode and battery 巴斯夫公司 2022-08-02 CN claimed
CN-113683780-B Antiserum and low-cytotoxicity polyamino acid gene delivery carrier material with membrane penetrating activity and nucleus positioning function 广州医科大学 2022-07-05 CN claimed
CN-114456019-A Porous TATB explosive spherulite and preparation method thereof 中国工程物理研究院化工材料研究所 2022-05-10 CN claimed
CN-113683780-A Antiserum and low-cytotoxicity polyamino acid gene delivery carrier material with membrane penetrating activity and nucleus positioning function 广州医科大学 2021-11-23 CN claimed
US-20160365228-A1 COMPONENT OF A PLASMA PROCESSING APPARATUS HAVING A PROTECTIVE IN SITU FORMED LAYER ON A PLASMA EXPOSED SURFACE LAM RESEARCH CORPORATION 2016-12-15 US claimed
US-9449797-B2 Component of a plasma processing apparatus having a protective in situ formed layer on a plasma exposed surface LAM RESEARCH CORPORATION (US) 2016-09-20 US claimed
US-20140335698-A1 COMPONENT OF A PLASMA PROCESSING APPARATUS HAVING A PROTECTIVE IN SITU FORMED LAYER ON A PLASMA EXPOSED SURFACE LAM RESEARCH CORPORATION (US) 2014-11-13 US claimed
EP-4739742-A1 LATENT CATALYST AND COATING COMPOSITIONS INCLUDING THE SAME SWIMC LLC (US) 2026-05-13 EP disclosed
US-12291506-B2 Method for producing amidate compound, and amidate compound KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-05-06 US disclosed
CN-119661373-A TATB crystal with fusiform micro-nano hierarchical structure and preparation method thereof 中国工程物理研究院化工材料研究所 2025-03-21 CN disclosed
WO-2025049313-A1 LATENT CATALYST AND COATING COMPOSITIONS INCLUDING THE SAME SWIMC LLC (US) 2025-03-06 WO disclosed
CN-115605525-B Uretdione-containing compositions that crosslink at low temperatures 科思创德国股份有限公司 2025-01-10 CN disclosed
US-20140335698-A1 COMPONENT OF A PLASMA PROCESSING APPARATUS HAVING A PROTECTIVE IN SITU FORMED LAYER ON A PLASMA EXPOSED SURFACE LAM RESEARCH CORPORATION (US) 2014-11-13 US disclosed
EP-2684872-A1 COMPOUND HAVING HEPTAMETHINE STRUCTURE, SENSITIZING DYE AND PHOTOELECTRIC CONVERSION ELEMENT Gifu University (JP) 2014-01-15 EP disclosed
US-20140005415-A1 IMMOBILIZATION OF IONIC LIQUIDS VIA MECHNOCHEMICAL INTERCALATION IN LAYERED MATERIALS TEXAS STATE UNIVERSITY-SAN MARCOS (US) 2014-01-02 US disclosed
US-20130291943-A1 PHOTOELECTRIC CONVERSION ELEMENT DAI-ICHI KOGYO SEIYAKU CO., LTD (JP) 2013-11-07 US disclosed
US-20120011886-A1 IONIC COMPOUNDS IN LITHIUM BROMIDE/WATER ABSORPTION CYCLE SYSTEMS E. I. DU PONT DE NEMOURS AND COMPANY 2012-01-19 US disclosed
WO-2011091131-A2 ESLICARBAZEPINE ACETATE AND ITS POLYMORPHS DR. REDDY'S LABORATORIES LTD. (IN) 2011-07-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12291506-B2 Method for producing amidate compound, and amidate compound NAAA, NIT2, PAM MEN1 55/4885HSP90AA1 4241/4885KMT2A 4207/4885
US-20140005415-A1 IMMOBILIZATION OF IONIC LIQUIDS VIA MECHNOCHEMICAL INTERCALATION IN LAYERED MATERIALS CALCOCO2, MCOLN2, MECP2 MEN1 689/4885HSP90AA1 4771/4885KMT2A 2295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.